The concept of an agile biological data science consulting company was initially conceived by three trailblazers in the bioinformatics world. Wim Van Criekinge, a professor in computational biology in University of Ghent, Gerben Menschaert, the faculty member of the same university, and Jan Van den Berghe, an entrepreneur and a close friend of Wim.
They realised that there are so many unanswered questions in the biological world, and genuinely believe that using the right tools such as data science, bioinformatics, biostatistics, machine learning, and AI, many of these problems can be solved. This led to the birth of BioLizard, a team of experienced bioengineers and computer science experts highly skilled in a full range of data science areas.
The industry is becoming extremely data-driven, and the integration of heterogeneous data in a dynamic environment is becoming central to success. At BioLizard we provide services tailored to our clients needs.
The name BioLizard originates from the fact that lizards are very agile and able to adapt to new environments, which adequately reflects the concept of our company. For this reason, we call our consultants, Lizards.
We provide services globally and collaborate with many organisations across the world.
What we doTo improve the quality and longevity of human life around the world by leveraging data better
To help our clients fully utilise their scientific data to increase their performance and ability to positively impact billions of lives globally
Dr. Liesbeth Ceelen has experience in a multinational environment as well as in start-up and scale-up companies. Over the last 15 years, she gained expertise in operational and quality management. Her key assets in this field are sales, scientific business development and strategic growth. Her role as CEO involves steering the BioLizard team, identifying and pursuing strategic opportunities with clients, as well as setting and driving metrics across business units.
Yves Muyssen is a data technology leader with 15+ years of experience in international technology companies, both in product-based as well as service-based ecosystems. He graduated as Bio-engineering and Computer Scientist and participated in many Strategy and Leadership courses. He combines experience in business strategy, organizational planning and people management with a deep understanding of software development and data management. As COO he helps translate the BioLizard strategy into operational goals and team organization. He leads a team of bioinformatics scientists, software engineers, data engineers and project managers.
Dr. Christian Rausch has several years of experience in the industry (NEB, DSM) and academia (Universität Tübingen, TU München, Vrije Universiteit Amsterdam Medical Center, Netherlands Cancer Institute). His main knowledge in bioinformatics is in the analysis of molecular sequences (DNA, RNA, protein), and structures (Synthetic biology, Protein Engineering) using advanced statistical and computational algorithms. As principle bioinformatics scientist, he heads the scientific team at BioLizard.
Dr. Volodimir Olexiouk is a highly experienced professional in the fields of AI and MLOps, with a proven track record of delivering data analytical solutions across a variety of sectors, particularly in the life sciences. He has a strong background in providing end-to-end solutions that are tailored to meet the specific needs of his clients and is well-versed in the leadership, management, and strategic planning required to successfully oversee data analytical projects and solutions. As the head of AI and Analytics at BioLizard, Dr. Olexiouk is responsible for leading a team of experts, managing the delivery of data analytical solutions, and developing the strategic roadmaps that guide the company’s services.
Paul is an experienced executive in innovative software product creation and management, including vision, strategy and execution. His focus on advanced data analytics and software architecture for health care, biotech, and life sciences applications, make him a perfect fit for BioLizard’s leadership team. Paul has worked on every aspect of the software product life cycle, and his expertise will be invaluable in helping BioLizard help their customers leverage the full potential of data for life sciences and health care.
Dr. Liesbeth Ceelen has experience in a multinational environment as well as in start-up and scale-up companies. Over the last 15 years, she gained expertise in operational and quality management. Her key assets in this field are sales, scientific business development and strategic growth. Her role as CEO involves steering the BioLizard team, identifying and pursuing strategic opportunities with clients, as well as setting and driving metrics across business units.
Prof. Wim Van Criekinge, together with Jan, is a co-founder of the Novalis Biotech Incubation. He is a tenured professor at the University of Gent, with nearly 200 peer-reviewed international publications to his name. He founded and heads the laboratory for computational genomics and bioinformatics (BIOBIX) as well as the core sequencing facility (NXTGNT) with global collaborative reach across applied bioscience and clinical discovery. He is a co-founder of BioLizard and he leads the scientific development of the company as well as coaching the consultants. His main interest is the use of machine learning in computational biology and bioinformatics.
Kjell Mortier (Pharm., PhD) is Fund Manager for Novalis Biotech Incubation. Prior to working for Novalis, Kjell acquired approximately 20-years experience in the biotech industry working in various scientific roles. At Ablynx, now part of Sanofi, he was responsible for the bioanalytical and immunogenicity part of dedicated clinical programs. At Eurofins, a leading CRO in the pharma, food and environmental industry, he supported the CMC-analytical part for various customers in the pharma industry. Kjell also obtained certification for financial analysis at EHSAL Management school.
Caroline Vanovermeire is the Global Director of Talent, Leadership, and Organisational Development at dentsu, a high growth, fast-paced marketing services, and solutions company. She is the founder of Effra Consult, a business that focuses on all things people to boost business performance. In addition, she is a mentor to start-ups in the FinTech industry. Caroline was previously the Global Head of Organisational Development for all Support functions at Barclays and a Principal at Heidrick & Struggles’ Global Leadership Advisory practice. Caroline is a trained psychologist and coach, she also has a Masters in Human Resources management.
Senior Executive with 30 years of Life Sciences experience and a proven track record in both mature and emerging markets in Western and Central Europe, Asia Pacific, and Middle East Africa. Successfully led organizations ranging from 40 to 1400 employees as CEO, Managing Director, and as Regional Vice President. He has extensive change management experience and broad Non-Executive and Advisory board experience. André holds an MBA degree from Tilburg University, and an MSc in Management from Purdue University, USA. He has also followed also the supervisory board member program of Nyenrode University, The Netherlands.
Senior executive and independent board member with more than thirty years of leadership experience and transformative strategies across numerous life science markets. Laurie has a proven track record of acceleration of impeccable commercial execution, leading to growth, profitability, global brand, and emerging market development. She has demonstrated the ability to build, galvanise, and mobilise global scientific and commercial teams. Her passion for leadership development, succession planning, and team followership, is realised by her unbounded resourceful problem-solving, creative strategies for a competitive edge, and market-dominant results.
Prof. Wim Van Criekinge, together with Jan, is a co-founder of the Novalis Biotech Incubation. He is a tenured professor at the University of Gent, with nearly 200 peer-reviewed international publications to his name. He founded and heads the laboratory for computational genomics and bioinformatics (BIOBIX) as well as the core sequencing facility (NXTGNT) with global collaborative reach across applied bioscience and clinical discovery. He is a co-founder of BioLizard and he leads the scientific development of the company as well as coaching the consultants. His main interest is the use of machine learning in computational biology and bioinformatics.
Prof. Gerben Menschaert is a co-founder of BioLizard and is an expert in bioinformatics, databases, and AI/Machine learning. He has worked for several years in both pharmaceutical and biotech companies (Janssen Pharmaceutica & deVGen) as a bioinformatician. His main focus is to combine different high throughput technologies and to integrate resulting information using bioinformatics tools to address different biological questions. At Biolizard, he provides expert advice for the bioinformatics team.
Prof. Thomas Krahn, is a scientific advisor and board member of BioLizard. He has almost 30 years of experience in the pharmaceutical industry as the head of department for several research units. His area of expertise is within the field of translational medicine, with a keen interest in the application of artificial intelligence and machine learning in the development of innovative diagnostic tools. As a scientific advisor, he provides invaluable insight and advice to the BioLizard Team.
Paul is an experienced executive in innovative software product creation and management, including vision, strategy and execution. His focus on advanced data analytics and software architecture for health care, biotech, and life sciences applications, make him a perfect fit for BioLizard’s leadership team. Paul has worked on every aspect of the software product life cycle, and his expertise will be invaluable in helping BioLizard help their customers leverage the full potential of data for life sciences and health care.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-advertisement | 1 year | Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category . |
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Cookie | Duration | Description |
---|---|---|
bcookie | 2 years | LinkedIn sets this cookie from LinkedIn share buttons and ad tags to recognize browser ID. |
lang | session | This cookie is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website. |
lidc | 1 day | LinkedIn sets the lidc cookie to facilitate data center selection. |
Cookie | Duration | Description |
---|---|---|
_ga | 2 years | The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors. |
_gat_gtag_UA_164325847_1 | 1 minute | This cookie is set by Google and is used to distinguish users. |
_gat_UA-164325847-1 | 1 minute | This is a pattern type cookie set by Google Analytics, where the pattern element on the name contains the unique identity number of the account or website it relates to. It appears to be a variation of the _gat cookie which is used to limit the amount of data recorded by Google on high traffic volume websites. |
_gcl_au | 3 months | Provided by Google Tag Manager to experiment advertisement efficiency of websites using their services. |
_gid | 1 day | Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously. |
Cookie | Duration | Description |
---|---|---|
_fbp | 3 months | This cookie is set by Facebook to display advertisements when either on Facebook or on a digital platform powered by Facebook advertising, after visiting the website. |
bscookie | 2 years | This cookie is a browser ID cookie set by Linked share Buttons and ad tags. |
fr | 3 months | Facebook sets this cookie to show relevant advertisements to users by tracking user behaviour across the web, on sites that have Facebook pixel or Facebook social plugin. |
Cookie | Duration | Description |
---|---|---|
a3aa548f857642d7ad9818410843280acd93d104c52e466aa7c59da011282bb0 | 1 year | No description |
AnalyticsSyncHistory | 1 month | No description |
li_gc | 2 years | No description |
UserMatchHistory | 1 month | Linkedin - Used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences. |